Table 1.

Patient’s characteristics

Parameters (n = 283)	Value n (%)
Age (years)	58.0 ± 12.1
Male/female	132 (47%) / 151 (53%)
Duration of diabetes, years	11 ± 6
DM Type
Type 1	15 (5%)
Type 2	268 (95%)
Comorbid diseases
Hypertension	200 (70%)
Hyperlipidemia	186 (66%)
Chronic kidney disease	108 (38%)
Coronary artery disease	81 (29%)
Cerebrovascular disease	17 (6%)
Pharmacotherapy type for DM
Dipeptidyl peptidase-4 inhibitors	130 (46%)
Metformin	158 (56%)
Sulfonylurea	32 (11%)
Sodium-glucose cotransporter-2 inhibitors	90 (32%)
Pioglitazone	17 (6%)
Glucagon-like peptide-1 receptor agonist	56 (20%)
Insulin	148 (52%)
Basal insulin	71 (25%)
Mixed insulin	28 (10%)
Intensive insulin	49 (17%)
Number of oral antidiabetic drug type
None	41 (14%)
One	107 (38%)
Two	88 (31%)
≥ 3	47 (17%)